Press Release Jun 10 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
This medication is used to treat bowel diseases such as ulcerative colitis and will be manufactured in Ahmedabad, India. The press release highlights that the product had significant annual sales in the United States.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jun 09 2023
- Press Release Jun 08 2023
- Press Release Jun 07 2023
- Press Release May 18 2023
- Press Release May 17 2023
Later from Zydus Lifesciences
- Press Release Jun 13 2023
- Press Release Jun 19 2023
- Press Release Jun 28 2023
- Press Release Jul 03 2023
- Press Release Jul 04 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences